Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 027665/0083 | |
| Pages: | 18 |
| | Recorded: | 02/07/2012 | | |
| Attorney Dkt #: | VPI/11-102 US & WO |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/09/2013
|
Application #:
|
13349845
|
Filing Dt:
|
01/13/2012
|
|
Publication #:
|
|
Pub Dt:
|
07/19/2012
| | | | |
|
Title:
|
SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA
|
|
|
Assignee
|
|
|
|
|
| 130 WAVERLY STREET |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
Correspondence name and address
|
| |
VERTEX PHARMACEUTICALS INCORPORATED
|
| |
130 WAVERLY STREET
|
| |
CAMBRIDGE, MA 02139
|
Search Results as of:
05/08/2024 09:43 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
